Acacia Pharma has a late-stage pipeline of nausea and vomiting product candidates for surgical and cancer patients; large and growing markets with significant unmet medical need.
Post-operative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
View PONV video
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
BARHEMSYS® Significantly Improves PONV in Rescue Treatment of Ambulatory Patients
Notice of Annual General Meeting
Complete Response Letter from FDA for BARHEMSYS®
View all news